COMMUNIQUÉS West-GlobeNewswire

CorMedix Completes Sale of $5.4 Million of NOL Tax Benefits Through New Jersey Economic Development Authority Program
17/04/2019
BERKELEY HEIGHTS, N.J., April 17, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
Blissco Orders Additional High CBD Hemp Following Successful CBD Oil Extraction
17/04/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, April 17, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
Radius Health to Present Two Posters at AACE 2019 Annual Meeting
17/04/2019
WALTHAM, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine [...]
Imagin Medical Welcomes World-Renowned Bladder Cancer Expert Dr. Ashish M. Kamat to Its Scientific Board of Advisors
17/04/2019
VANCOUVER, British Columbia and BOSTON, April 17, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that Dr. Ashish M [...]
Inovalon Announces First Quarter 2019 Earnings Conference Call
17/04/2019
BOWIE, Md., April 17, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that it will hold a [...]
Blueberries Medical Appoints Former Abbott Laboratories/AbbVie Pharmaceutical Executive Eduardo Molinari as Chief Marketing Officer
17/04/2019
Strategic Hire Adds Further Latin American and International Pharmaceutical Industry Experience to Management Team TORONTO, April 17, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: [...]
Intensity Therapeutics Receives Fast Track Designation from U.S. FDA for Development of INT230-6 as Treatment for Relapsed or Metastatic Triple Negative Breast Cancer
17/04/2019
WESTPORT, Conn., April 17, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc. , a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection [...]
Spark Therapeutics Announces Sponsorship of Believe Limited’s First-Ever Science Fair for the Hemophilia Community at 2019 National Hemophilia Foundation’s Bleeding Disorders Conference
17/04/2019
The Science Fair™ aims to engage and educate patients, families and caregivers affected by bleeding PHILADELPHIA, April 17, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene [...]
Radient Technologies Inc. Appoints Two New Members to its Board of Directors
17/04/2019
EDMONTON, Alberta, April 17, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that it has appointed Ms. Jocelyne F. Lafrenière and [...]
Why Women, the Fastest Growing Consumers of Cannabis, are the Demographic to Watch -- CFN Media
17/04/2019
SEATTLE, April 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]
ADMA Biologics Granted U.S. Patent for Treatment and Prevention of Pneumococcal Infections
17/04/2019
Fifth Patent Issued to the Company in the U.S. Provides Coverage for Expanding the Company’s Hyperimmune IVIG Portfolio Through 2037 RAMSEY, N.J. and BOCA RATON, Fla., April 17, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, [...]
Myriad Genetics Named to Forbes 2019 List of America's Best Midsize Employers and the Women Tech Council’s 2019 Shatter List
17/04/2019
Creating a Culture of Diversity, Inclusion and Opportunity Is a Top Company Priority SALT LAKE CITY, April 17, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, [...]
iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A2A Antagonist in Patients with Advanced Cancer
17/04/2019
iTeos Therapeutics Initiates Phase 1/1b Trial with Differentiated Adenosine A 2A Antagonist in Patients with Advanced Cancer First cohort of patients with advanced cancer now dosed with EOS100850 Target enrollment of 72 [...]
Revive Therapeutics Announces United States Patent Grant for Cannabinoid Delivery System
17/04/2019
TORONTO, April 17, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development and [...]
OraSure Technologies Earnings Conference Call Invitation
17/04/2019
2019 First Quarter Earnings Conference Call Wednesday, May 8, 2019, 5:00 p.m. ET BETHLEHEM, Pa., April 17, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference [...]
Precision BioSciences Announces Dosing of First Patient in Off-The-Shelf CAR T Cell Therapy Phase 1/2a Clinical Trial
17/04/2019
First NHL patient treated with allogeneic CAR T in U.S.-based trial DURHAM, N.C., April 17, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving [...]
Correction: Announcement no. 3/2019 - Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse
17/04/2019
Announcement no. 3/2019 17 April 2019 Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse Coloplast was informed yesterday by the FDA that the PMA for [...]
Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse
17/04/2019
Coloplast was informed yesterday by the FDA that the PMA for Restorelle DirectFix Anterior is not approved and the company must cease marketing and distribution immediately. As a result, FDA regulations require that all [...]
Zealand Pharma announces amendments to its Articles of Association following the granting of warrants
17/04/2019
Company announcement – No. 14 / 2019 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, April 17, 2019 – Zealand Pharma (“Zealand”) announces that its [...]

Pages